![ARDD](/img/default-banner.jpg)
- 356
- 577 150
ARDD
Denmark
Registrace 17. 09. 2020
This is the channel for the Aging Research and Drug Discovery meeting (www.agingpharma.org). We reserve the right to remove derogatory, personal and/or non-scientific comments.
Nicole Sirotin, MD 🔴 Institute for Healthier Living Abu Dhabi 🔴Interviews with Sponsors 🔴ARDD24
Dominika Wilczok interviews Dr. Nicole Sirotin: the CEO of the Institute for Healthier Living Abu Dhabi, which is the tier 2 sponsor of ARDD24!
🔴Nicole Sirotin, MD, is a beacon of inspiration in the field of Lifestyle Medicine, known for her vibrant approach to guiding patients toward lives brimming with health, joy, and fulfillment. As a passionate leader, she has become a renowned figure in the UAE, celebrated for her innovative health programs, dynamic team leadership, and the powerful message that our daily choices profoundly impact our health and lifespan.
Dr. Sirotin's vision in leadership is to make positive changes and redefine the future trajectory of healthcare. She is committed to fostering a healthcare environment that prioritizes scientific advancements in prevention and precision medicine. Her innovative approach and dedication are paving the way for a new era in healthcare, one where long-term health and vitality are within everyone's reach.
For the past 10 years, Dr. Sirotin has played a pivotal role at Cleveland Clinic Abu Dhabi (CCAD), which has earned the distinction of being the top hospital in the UAE and GCC. Initially spearheading the Internal Medicine Department, she then established the Department of Preventive Medicine and held the position of Medical Director for the Office of Facilitated Access at CCAD. This division encompasses a concierge-style primary care practice, a comprehensive Lifestyle Medicine program, and the esteemed CCAD Executive Health program.
Dr. Sirotin's work in Lifestyle Medicine is transformative, combining a unique approach within the UAE by applying the principles of precision medicine with personalized scientific lifestyle strategies to help patients prevent and reverse diseases. One of her most significant achievements is the creation of and implementation of a groundbreaking Lifestyle Medicine program within the CCAD Cancer Center. This program ensures that every cancer patient receives precise treatment aimed at reducing side effects, minimizing recurrence, and improving overall survival rates.
Currently serving as the Chief Executive Officer at the Institute of Healthy Living Abu Dhabi. She is also a Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine and has taught at Weill Cornell Medical College and Albert Einstein College of Medicine. Her educational background includes a medical degree from the University of Medicine and Dentistry of New Jersey, a residency in Primary Care/General Internal Medicine at the University of California, San Francisco, focusing on Health Equities, and a research fellowship in Global Public Health at the University of California, San Diego. Her dedication to medicine has been recognized with several prestigious awards, including the 2019 “Physician of the Year” from the Cleveland Clinic Abu Dhabi Women’s Professional Staff Association and the 2008 UCSF Exceptional Physician Award.
Outside of her professional endeavors, Dr. Sirotin enjoys the vibrant lifestyle of Abu Dhabi with her husband, Joshua, and their son, Finley. She loves hiking, traveling, savoring delicious food, exploring new knowledge, and immersing herself in the soulful sounds of the blues. Dr. Sirotin’s life and career are a testament to her belief that “each day is a new opportunity to embrace health and vitality,” a philosophy she passionately imparts to her patients and community.
🔴Dominika Wilczok is a researcher focusing on AI-driven approaches to combat aging. Her current projects include using Large Language Models (LLMs) to prioritize geroprotectors and developing autonomous agents for hypothesis testing in longevity science.Dominika has presented her work at international conferences' poster sessions, including the International Society on Aging and Disease 2023 and Nature's "Advancing Health with AI" symposium. She is a coordinator at the Longevity Education Hub, an analyst at Longevity.Technology and Biopharma.Trend, and a member of the scientific communication team at Haut.AI.Dominika is pursuing a dual degree at Duke University and Duke Kunshan University, furthering her expertise in longevity research.
🔴Learn more about ARDD at agingpharma.org and about IHLAD at www.linkedin.com/company/ihlabudhabi/?originalSubdomain=ae
🔴Nicole Sirotin, MD, is a beacon of inspiration in the field of Lifestyle Medicine, known for her vibrant approach to guiding patients toward lives brimming with health, joy, and fulfillment. As a passionate leader, she has become a renowned figure in the UAE, celebrated for her innovative health programs, dynamic team leadership, and the powerful message that our daily choices profoundly impact our health and lifespan.
Dr. Sirotin's vision in leadership is to make positive changes and redefine the future trajectory of healthcare. She is committed to fostering a healthcare environment that prioritizes scientific advancements in prevention and precision medicine. Her innovative approach and dedication are paving the way for a new era in healthcare, one where long-term health and vitality are within everyone's reach.
For the past 10 years, Dr. Sirotin has played a pivotal role at Cleveland Clinic Abu Dhabi (CCAD), which has earned the distinction of being the top hospital in the UAE and GCC. Initially spearheading the Internal Medicine Department, she then established the Department of Preventive Medicine and held the position of Medical Director for the Office of Facilitated Access at CCAD. This division encompasses a concierge-style primary care practice, a comprehensive Lifestyle Medicine program, and the esteemed CCAD Executive Health program.
Dr. Sirotin's work in Lifestyle Medicine is transformative, combining a unique approach within the UAE by applying the principles of precision medicine with personalized scientific lifestyle strategies to help patients prevent and reverse diseases. One of her most significant achievements is the creation of and implementation of a groundbreaking Lifestyle Medicine program within the CCAD Cancer Center. This program ensures that every cancer patient receives precise treatment aimed at reducing side effects, minimizing recurrence, and improving overall survival rates.
Currently serving as the Chief Executive Officer at the Institute of Healthy Living Abu Dhabi. She is also a Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine and has taught at Weill Cornell Medical College and Albert Einstein College of Medicine. Her educational background includes a medical degree from the University of Medicine and Dentistry of New Jersey, a residency in Primary Care/General Internal Medicine at the University of California, San Francisco, focusing on Health Equities, and a research fellowship in Global Public Health at the University of California, San Diego. Her dedication to medicine has been recognized with several prestigious awards, including the 2019 “Physician of the Year” from the Cleveland Clinic Abu Dhabi Women’s Professional Staff Association and the 2008 UCSF Exceptional Physician Award.
Outside of her professional endeavors, Dr. Sirotin enjoys the vibrant lifestyle of Abu Dhabi with her husband, Joshua, and their son, Finley. She loves hiking, traveling, savoring delicious food, exploring new knowledge, and immersing herself in the soulful sounds of the blues. Dr. Sirotin’s life and career are a testament to her belief that “each day is a new opportunity to embrace health and vitality,” a philosophy she passionately imparts to her patients and community.
🔴Dominika Wilczok is a researcher focusing on AI-driven approaches to combat aging. Her current projects include using Large Language Models (LLMs) to prioritize geroprotectors and developing autonomous agents for hypothesis testing in longevity science.Dominika has presented her work at international conferences' poster sessions, including the International Society on Aging and Disease 2023 and Nature's "Advancing Health with AI" symposium. She is a coordinator at the Longevity Education Hub, an analyst at Longevity.Technology and Biopharma.Trend, and a member of the scientific communication team at Haut.AI.Dominika is pursuing a dual degree at Duke University and Duke Kunshan University, furthering her expertise in longevity research.
🔴Learn more about ARDD at agingpharma.org and about IHLAD at www.linkedin.com/company/ihlabudhabi/?originalSubdomain=ae
zhlédnutí: 138
Video
Kennedy Schaal 🔴 Rejuve.Bio 🔴 Interviews with Sponsors 🔴ARDD24
zhlédnutí 95Před 20 hodinami
Dominika Wilczok interviews Kennedy Schaal: the CEO and Founder of Rejuve.Bio, the tier 4 sponsor of ARDD! 🔴 Kennedy Schaal is an accomplished biotechnology executive with strong leadership track record in applied genomic research and Artificial Intelligence at the frontier of longevity science. She is a multi-published author on the science of longevity and applied genomics trials. World leadi...
Hal Gunn, MD 🔴QuBiologics 🔴Interviews with Sponsors 🔴 ARDD24
zhlédnutí 64Před 20 hodinami
Dominika Wilczok interviews Dr. Hal Gunn: the founder and CEO of QuBiologics, the tier 3 sponsor of ARDD! 🔴Hal Gunn, MD, founder and CEO of Qu Biologics, is a physician-entrepreneur who has focused his professional life to understanding how to support the body’s innate immune capacity to heal. Dr. Gunn co-founded InspireHealth, Canada’s foremost supportive cancer care centres, to support the he...
Tallyhealth 🔴Melanie Goldey 🔴 Interviews with Sponsors 🔴 ARDD24
zhlédnutí 57Před 23 hodinami
Andrea Olsen interviews Tally Health's CEO Melanie Goldey. Tally Health is the tier 3 sponsor of #ARDD24! 🔴Melanie is a dynamic executive with deep expertise driving strategic and operational excellence and building world-class teams at technology-enabled, high-growth, public and private companies through periods of scale and transformation. Extensive experience in fundraising, M&A, and navigat...
Healthspan Capital 🔴Sebastian A. Brunemeier 🔴 Interviews with Sponsors 🔴 ARDD24
zhlédnutí 141Před 14 dny
We are happy to present an interview with Sebastian A. Brunemeier: the co-founder and general partner at Healthspan Capital - Tier 5 sponsor of #ARDD24! Dominika Wilczok interviews Sebastain about venture capital in longevity biotechnology and ups and downs of longevity entrepreneurship. 🔴Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. H...
HautAI 🔴 Anastasia Georgievskaya 🔴 Interviews with Sponsors 🔴 ARDD24
zhlédnutí 94Před 14 dny
We are happy to present the interview with HautAI, the Tier 5 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Anastasia Georgievskaya is the CEO and co-founder of Haut.AI (haut.ai/), an Estonian AI-powered skin analytics SaaS platform delivering uniquely personalized skincare recommendations and diagnostics for retail and skin wellness applications. 🔴Timestamps Introduc...
Life Biosciences 🔴Sharon Rosenzweig-Lipson, PhD 🔴 Interviews with Sponsors 🔴 ARDD 2024
zhlédnutí 499Před 21 dnem
In this episode, Dominika Wilczok talks with Dr Sharon Rosenzweig-Lipson, the chief scientific officer at Life Biosciences, the tier 3 sponsor of ARDD 2024! www.lifebiosciences.com/ 🔴Dr. Rosenzweig-Lipson is the Chief Scientific Officer for Life Biosciences, Inc. She has held leadership positions in both big pharma and small biotechnology companies over the course of her 30 year career. She has...
Repair Biotechnologies 🔴 Reason 🔴 Interviews with Sponsors 🔴 ARDD24
zhlédnutí 126Před 21 dnem
We are happy to present the interview with Repair Biotechnologies, the Tier 3 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dominika Wilczok talks with Reason, the co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeuti...
AniBiome 🔴 Bruno Balen 🔴 Interview with Sponsors 🔴ARDD24
zhlédnutí 65Před 21 dnem
We are happy to present the interview with AniBiome, the Tier 3 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dominika Wilczok talks with Bruno Balen, the cofounder at Ani Biome, a longevity biotech startup focused on the gut-brain axis and mental health. The company has developed an ML architecture for non-invasive digital diagnostics and the personalization of a syn...
Longevity Science Foundation 🔴 Lisa Ireland 🔴Interviews with Sponsors 🔴 ARDD24
zhlédnutí 75Před 21 dnem
We are happy to present the interview with the Longevity Science Foundation, the Tier 5 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dominika Wilczok talks with Lisa Ireland, the president and CEO of the foundation. Ireland, an accomplished nonprofit executive with more than 25 years of experience in administration, fundraising, donor engagement, strategy, and financ...
NadMed 🔴Jari Närhi 🔴 Interviews with Sponsors 🔴ARDD24
zhlédnutí 47Před 21 dnem
We are happy to present the interview with NADMED, the Tier 5 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dominika Wilczok talks with Jari Närhi, the CEO and Co-Founder at NADMED. He has senior level experience from health care technology and services, information technology, information security, and business consulting. He has worked and lived in three continents,...
Turn Biotechnologies 🔴 Sergio Ruiz 🔴 Interviews with Sponsors 🔴ARDD24
zhlédnutí 79Před 28 dny
We are happy to present the interview with Turn Biotechnologies, the Tier 3 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dominika Wilczok talks with Sergio Ruiz is the co-founder and COO at Turn Biotechnologies www.turn.bio/. As an entrepreneur, philanthropist and investor, Sergio has worked with several biotechnologies designed to increase healthy lifespan. He is a ...
ARDD24 🔴 Interviews with Sponsors 🔴 Seraphina Therapeutics 🔴Stephanie Venn-Watson, DVM, MPH
zhlédnutí 132Před 28 dny
We are happy to present the interview with Seraphina Therapeutics, the Tier 3 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dr Stephanie Venn-Watson is the co-founder and CEO at Seraphina Therapeutics: seraphinatherapeutics.com/ and Fatty15 fatty15.com/pages/stephanie-venn-watson 🔴Publications mentioned in the interview: Broader and safer clinically-relevant activitie...
ARDD24 🔴Interviews with Sponsors 🔴InsideTracker 🔴Gil Blander, PhD
zhlédnutí 93Před měsícem
We are happy to present the interview with InsideTracker, the Tier 3 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Dominika Wilczok talks with Gil Blander: the Chief Scientific Officer at InsideTracker www.insidetracker.com/. 🔴Timestamps: 0:00 - 0:23 Introduction 0:24 - 1:48 InsideTracker's unique approach to longevity and health optimization 1:49 - 3:13 Motivation fo...
ARDD24 🔴Interview with Sponsors 🔴 Accelerated Bisciences 🔴 Yuta Lee
zhlédnutí 99Před měsícem
We are happy to present the interview with Accelerated Biosciences Corporation, the Tier 3 sponsor of the Aging Research and Drug Discovery conference, ARDD, 2024! Yuta Lee is the founder and CEO at Accelerated Biosciences Corporation: www.acceleratedbio.com/ 🔴Timestamps: 0:00 - 1:12 Accelerated Biosciences' unique platform and approach to longevity 1:13 - 3.56 Yuta's personal motivation for en...
ARDD24 🔴 Interviews with Sponsors 🔴 Healthy Longevity Clinic 🔴 Petr Sramek
zhlédnutí 68Před měsícem
ARDD24 🔴 Interviews with Sponsors 🔴 Healthy Longevity Clinic 🔴 Petr Sramek
ARDD24 🔴 Interview with Sponsors 🔴 TruDiagnostic 🔴 Hannah Went
zhlédnutí 100Před měsícem
ARDD24 🔴 Interview with Sponsors 🔴 TruDiagnostic 🔴 Hannah Went
ARDD24🔴 Interview with Sponsors 🔴 XPRIZE Healthspan🔴 Prof. Jamie Justice
zhlédnutí 181Před měsícem
ARDD24🔴 Interview with Sponsors 🔴 XPRIZE Healthspan🔴 Prof. Jamie Justice
Gabor Gyülveszi from Rejuveron at ARDD2023: Rejuveron: multifocal approach to tackle longevity.
zhlédnutí 1,1KPřed 8 měsíci
Gabor Gyülveszi from Rejuveron at ARDD2023: Rejuveron: multifocal approach to tackle longevity.
Anja Groth at ARDD2023: Maintaining epigenome fidelity across cell divisions - implications for...
zhlédnutí 1,5KPřed 8 měsíci
Anja Groth at ARDD2023: Maintaining epigenome fidelity across cell divisions - implications for...
Richard Faragher at ARDD2023: The body and beyond: Therapeutic Opportunities Presented by...
zhlédnutí 810Před 8 měsíci
Richard Faragher at ARDD2023: The body and beyond: Therapeutic Opportunities Presented by...
Laura Niedernhofer at ARDD2023: Pre-clinical models for testing geroprotectors
zhlédnutí 584Před 8 měsíci
Laura Niedernhofer at ARDD2023: Pre-clinical models for testing geroprotectors
David Sinclair at ARDD2023: Epigenetic stabilization and reprogramming: an update
zhlédnutí 64KPřed 8 měsíci
David Sinclair at ARDD2023: Epigenetic stabilization and reprogramming: an update
Liesbeth Veenhoff at ARDD2023: Poor old Pores; Surveillance of the intrinsically disordered ...
zhlédnutí 406Před 8 měsíci
Liesbeth Veenhoff at ARDD2023: Poor old Pores; Surveillance of the intrinsically disordered ...
Sergey Jakimov at ARDD2023: 2 years into longevity investing - approach and challenges
zhlédnutí 491Před 8 měsíci
Sergey Jakimov at ARDD2023: 2 years into longevity investing - approach and challenges
Paul Robbins at ARDD2023: Novel senotherapeutic approaches to extend healthspan
zhlédnutí 971Před 8 měsíci
Paul Robbins at ARDD2023: Novel senotherapeutic approaches to extend healthspan
Dario Valenzano at ARDD2023: Evolution and Ecology of Aging
zhlédnutí 531Před 8 měsíci
Dario Valenzano at ARDD2023: Evolution and Ecology of Aging
Adam Antebi at ARDD2023: A tale of old and new love: Insights into longevity and rejuvenation from..
zhlédnutí 674Před 8 měsíci
Adam Antebi at ARDD2023: A tale of old and new love: Insights into longevity and rejuvenation from..
John Speakman at ARDD2023: Stepping stones towards anti-ageing drug discovery
zhlédnutí 638Před 8 měsíci
John Speakman at ARDD2023: Stepping stones towards anti-ageing drug discovery
Bla bla bla…..
Stop funding Washington DC and start funding science of scientists and doctors Last 40 years were a waste of trillions 😳😳😳🍳
From DIscord: "Obviously only a few slides, but RPE reprogramming data @ 12:55 in a mouse model of macular degeneration, and neuron reprogramming data @ 14:25. IMO the new optomotor acuity data in mice w/ reprogrammed RPE cells look better than in their prior work in the optic nerve, but these are very different diseases/models so such a comparison isn't really appropriate, especially without data from a full paper (I'm just trying to put into context the extent of vision improvement here). Also they used an iodide model of macular degeneration - but presumably in older mice that are 12 months old, which is still quite young - which while is a standard mouse model in eye research I doubt it recapitulates normal aging and/or age-related macular degeneration well. David also presents some early MIB-626 (his company's NMN) human trial data showing potential improvements in a few cardiovascular biomarkers like total cholesterol, non-HDL cholesterol, and also improved weight loss"
Breakthrough, Excellent , Doctor's
I can’t spend 20 years in 24/7 pain with chronic disease 😭
Absolutely ❤
How can you have a low calorie yet high fat diet?
I’m looking forward to the results from the fisetin study. Or did it fail??
I have osteoarthritis and needing two hips i want to volunteer for drug trials, is this possible, im healthy, non smoker, can anyone help me
Very interesting.. i Think it won't be on the public radar.. in most countries... or every public pension system will collapse.. The ideal for a government should be stay healthy until a defined age and then die.. live longer = bankrupt (I obviously assume it won't be possible to quickly increase retirement age for most of the jobs)
Google: GlaxoSmithKline and David Sinclair. You’ll come to know more about David. A lot more.
You are brilliant! Thank you for your research!
On VL's comment about not being a ketogenic diet it nevertheless raises ketones and lowers glucose, alot. I've done the official FMD and my own version based on the macro breakdown and in all case my ketones went up to clinical levels (.0.5 mmol) in the 2 to 3 mmol range by day 3 of 5. I take this as just a marker of low insulin. My glucose went down to 70s from high 80s/low 90s. Highly recommended. But do before and after blood work. And when you come out of transition to a good diet and TRE if you can. I did the FMD as two meals/day about 8 hours apart, so a form of TRE combined with FMD.
Os it just me or did she describe a great leap forward to cure blindness...
In his book, Longo shows how to do a DIY version of the FMD. Very easy. I do it once a year.
Yes, I designed my own after doing the official version 3 times. Works very well - Using ketone and glucose levels as markers my version gave same results.
Very interesting. Never heard much about IL-11 before.
Thank you so much! Muchas gracias from Mexico!
Muchas gracias, thank you so much
Very interesting talk. Love biology
Vittorio Sebastiano from Turn Biotechnologies presented at the 10th Aging Research and Drug Discovery conference on cellular and tissue rejuvenation through epigenetic reprogramming. The key points from his presentation are: 1. Epigenetic drift, the progressive accumulation of epigenetic errors in the epigenome, is believed to be a fundamental driver of cellular aging and loss of function. Over time, genes that should be off get turned on and vice versa, impacting many hallmarks of aging. However, unlike the genetic code, the epigenome is reversible and can potentially be reset. 2. Inspiration for epigenetic reprogramming comes from the works of John Gurdon and Shinya Yamanaka showing that somatic cells can be reprogrammed into embryonic-like cells through somatic cell nuclear transfer (Gurdon) or induced pluripotent stem cell techniques (Yamanaka). This suggests aged cells could potentially be made more youthful. 3. In 2014, Sebastiano's group proposed using a controlled partial/transient reprogramming approach to change the age of cells without altering cell identity. They published foundational work on this "epigenetic reprogramming of aging" (ERA) in 2020 using a cocktail of 6 factors delivered as mRNAs. Since then, several studies have validated the approach in various tissues (muscle, skin, brain etc.) and organisms (mice, rats, primates). 4. Turn Biotechnologies is working to translate ERA into clinical applications by combining the biological concept, mRNA delivery vehicles, and lipid nanoparticle (LNP) delivery systems. Using mRNA avoids genomic integration risks and allows fine control of factor expression. Certain factors like MECP2 have beneficial effects when pulsed briefly in combination with others, contrary to some misconceptions. 5. In dermatology, ERA shows promising results: - In primary human fibroblasts, it causes transcriptomic resetting with activation of ECM related genes, anti-inflammatory effects etc. Fibroblast identity genes are appropriately modulated. - In human skin biopsies cultured ex vivo, aging biomarkers are favorably altered after ERA treatment. - An in vivo human skin xenograft model was developed to test ERA delivery and efficacy over several weeks. 6. For immunology, ERA is being explored to rejuvenate T cells: - Treated T cells from old donors proliferate robustly in response to tumor cells without any change in cell identity markers. - They express lower levels of exhaustion markers and maintain better anti-tumor cytotoxic function compared to controls. 7. ERA has potential applications in many tissues like muscle, eye, cartilage, blood, and skin, with dermatology and immunology being the initial focus areas. 8. Delivery of mRNA remains a key challenge, especially achieving sufficient penetration. For skin, microneedling/injections are the near-term approach, with topical solutions being developed. Broader interest and investment in mRNA and gene therapies, catalyzed by COVID vaccines, is expected to accelerate progress on novel delivery systems. In conclusion, Sebastiano presented compelling evidence for ERA as a promising approach to partially reverse cellular aging through transient epigenetic reprogramming. By translating ERA into viable clinical therapies, Turn Bio aims to ultimately increase human healthspan. While delivery hurdles remain, the underlying biology appears sound and reproducible across contexts. ERA represents an exciting frontier in the fight against aging and age-related dysfunction.
Thank you for the great summary :)
Doing my first round of FMD. Primarily interested in anti cancer. Wondering if alternating the FMD with a vegan KETO would stress cancer cells more than just FMD. Example, month 1, FMD, month 2 Ketogenic diet (5 days).
Thanks. Very important. As a 69 yo male very encouraging as I exercise daily these last 12 years. Hba1c stays ~ 5% and hsCRP at <= 0.3 mg/L consistently. Will test IL-6 on morning before exercise to confirm it is low.
The research is absolutely stunning and many people are pending from any news regarding this study. However, I think the difference between targeting "degenerating" or "dead" retina cells in the end of the talk, could have worth a bit more time explanation. Also, do you plan a glaucoma model for the non-human primate test?
I've read his book lifespan couple weeks ago.. and thereafter I'm looking for his interviews
If he becomes my teacher, I’d be honored.
That is amazing!! I will like to hear more...l would like also read the book Lifespan!!😊by David!!
Pure NMN powder from donotage is really good.
I would like to know you said this company is going to make NMN Into a drug, how is that going to affect the rest of the people that you are educating on his benefits, to me that would limit it greatly as to who can get it?
I wonder if he has looked at senescent cells? Are they reduced as in senolytic therapies?
So VERY DISAPPOINTED that you are associated with the WEF. As we all know Klaus Schwab, Gates and the WEF are for depopulation of the world by billions!! Unless these supplements are only for the elites I am very hesitant to believe what is presented. Maybe the average "useless eater", as Klaus calls the general population is not supposed to hear this information or take the supplements!
Did I hear him claim to have dead lifted almost 1,000 pounds?? If so can't he hold a stationary Iron Cross on still rings with 100 extra pounds strapped around his waist?
Did he say, penguins are mammals?
Methionine is better then acuall sam-e for creating sam e and having a anti depressive effect new studies show. Yet many years back aging docs pushed that methionine restriction increase lifespan. Wich makes no sense as methionine is a must for methylation and sam e creation.
I want to move to Singapore now.
Seems criminal that I can't make an informed decision by myself to use rapamycin and take the risks: the possible rewards seem worth it. The whole "we need rapalogues cuz pharma isn't interesting in rapamycin cuz it can't be patented is infuriating.
really the one person to ask a question was some girl who wanted to know what to study...great way to waste it...🙄
I can tell he is a toxic PI the way he talks about his student
She seemed very nervous, but she did a great job. Very interesting talk.
I have done the Prolon 5 day fasting mimicking diet and having the prescribed food made it possible to tolerate the diet because extreme hunger wasn't a factor. I believe in Dr. Longo's research.
Love this
Thank you very much for your valuable information ♥👍👍
What is the mechanism to revert age by applying four Yamanaka factors?
A very interesting talk and subject. I'm surprised so few seems to react on it. Only one comment, for example!
A price implies a selective process that perpetuates the cycle of disenfranchisement for those who have no substantial income beyond housing and food.
Wow, that is super-exciting research. Great talk.
Fantastic. Dr.Coray provides comprehensive evidences to prove this old prediction is true.
Bus drive surely could have waited one more question, you have David Sinclair on stage. Come on!
❤❤❤
This was most interesting! The connection between mitocondria and senescence is new to me, and seems to change things compleatly. The similarity between apoptosis and senescence is intriguing! I wonder what effect PhotoBioModulation would have on senescencent cells. Since that affects the mitocondria. Would it push them into apoptosis, into recovery, or neither?